Toxicity of silver nanoparticles in monocytes and keratinocytes: Potential to induce inflammatory reactions

Central-European Journal of Immunology

Volumn 37, Issue 2, 2012, Pages 123-130

  Orłowski, Piotr ^a   Krzyzowska, Małgorzata ^a   Winnicka, Anna ^a   Chwalibóg, André ^b   Sawosz, Ewa ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Apoptosis; Keratinocytes; Monocytes; Silver nanoparticles; Toxicity

Indexed keywords

ANTIINFECTIVE AGENT; CASPASE 9; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN BAX; SILVER NANOPARTICLE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; ENZYME ACTIVITY; IMMUNOTOXICITY; IN VITRO STUDY; INFLAMMATION; KERATINOCYTE; MACROPHAGE; MATERIAL COATING; MEDICAL DEVICE; MONOCYTE; MOUSE; NONHUMAN; PARTICLE SIZE; PROTEIN EXPRESSION; WOUND DRESSING;

EID: 84862273890     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Atiyeh BS, Costagliola M, Hayek SN, Dibo SA (2007): Effect of silver on burn wound infection control and healing: review of the literature. Burns 33: 139-148. (Pubitemid 46188672)
2. Klasen HJ (2000): Historical review of the use of silver in the treatment of burns. I. Early uses. Burns 26: 117-130.
3. Moyer CA (1965): A treatment of burns. Trans Stud Coll Physicians Phila 33: 53-103.
4. De Wild M, Berner S, Suzuki H, et al. (2003): Molecular assembly and self-assembly: molecular nanoscience for future technologies. Ann N Y Acad Sci 1006: 291-305. (Pubitemid 38064789)
5. Hilger A, Cüppers N, Tenfelde M, Kreibig U (2000): Surface and interface effects in the optical properties of silver nanoparticles. Eur Phys J D 10: 115-118.
6. Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC (2005): In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 88: 412-419. (Pubitemid 41672149)
7. Martin P, D'Souza D, Martin J, et al. (2003): Wound healing in the PU.1 null mouse - tissue repair is not dependent on inflammatory cells. Curr Biol 13: 1122-1128. (Pubitemid 36815260)
8. Lucas T, Waisman A, Ranjan R, et al. (2010): Differential roles of macrophages in diverse phase of skine repair. J Immunol 184: 3964-3977.
9. Barker JN, Mitra RS, Griffiths CE, et al. (1991): Keratinocytes as initiators of inflammation. Lancet 337: 211-214.
10. Barker JN, Jones ML, Mitra RS, et al. (1991): Modulation of keratinocyte-derived interleukin-8 which is chemotactic for neutrophils and T lymphocytes. Am J Pathol 139: 869-876.
11. Pivarcsi A, Nagy I, Kemeny L (2005): Innate immunity in the skin: how keratinocytes fight against pathogens. Curr Immunol Rev 1: 29-42.
12. Hari A, Flach TL, Shi Y, Mydlarski PR (2010): Toll-like receptors: role in dermatological disease. Mediators Inflamm 2010: 437246.
13. Matsubara M, Harada D, Manabe H, Hasegawa K (2004): Staphylococcus aureus peptidoglycan stimulates granulocyte macrophage colony-stimulating factor production from human epidermal keratinocytes via mitogen-activated protein kinases. FEBS Lett 556: 195-200. (Pubitemid 38625957)
14. Midorikawa K, Ouhara K, Komatsuzawa H, et al. (2003): Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect Immun 71: 3730-3739. (Pubitemid 36753693)
15. Wollina U, Künkel W, Bulling L, et al. (2004): Candida albi-cans- induced inflammatory response in human keratinocytes. Mycoses 47: 193-199.
16. van der Veer WM, Bloemen MC, Ulrich MM, et al. (2009): Potential cellular and molecular causes of hypertrophic scar formation. Burns 35: 15-29.
17. Park EJ, Yi J, Kim Y, et al. (2010): Silver nanoparticles induce cytotoxicity by Trojan-horse type mechanism. Toxicol In Vitro 24: 872-878.
18. Kuida K (2000): Caspase-9. Int J Biochem Cell Biol 32: 121-124.
19. MacKenzie A, Wilson HL, Kiss-Toth E, et al. (2001): Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15: 825-835. (Pubitemid 34008509)
20. Pizzirani C, Ferrari D, Chiozzi P, et al. (2007): Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. Blood 109: 3856-3864. (Pubitemid 46641737)
21. Fink SL, Cookson BT (2006): Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol 8: 1812-1825. (Pubitemid 44530672)
22. Bergsbaken T, Fink SL, den Hartigh AB, et al. (2011): Coordinated host responses during pyroptosis: caspase-1-dependent lysosome exocytosis and inflammatory cytokine maturation. J Immunol 187: 2748-2754.
23. Rai M, Yadav A, Gade A (2009): Silver nanoparticles as new generation of antimicrobials. Biotechnol Adv 27: 76-83.
24. Gao Y, Cranston R (2008): Recent advances in antimicrobial treatments of textiles. Text Res J 78: 60-72. (Pubitemid 351356504)
25. Park J, Lim DH, Lim HJ, et al. (2011): Size dependent macrophage responses and toxicological effects of Ag nanoparticles. Chem Commun (Camb) 47: 4382-4384.
26. Zanette C, Pelin M, Crosera M, et al. (2011): Silver nanoparticles exert a long-lasting antiproliferative effect on human keratinocyte HaCaT cell line. Toxicol In Vitro 25: 1053-1063.
27. Hussain SM, Hess KL, Gearhart JM, et al. (2005): In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19: 975-983. (Pubitemid 41563236)
28. Chen X, Schluesener HJ (2008): Nanosilver a nanoproduct in medical application. Toxicol Lett 176: 1-12.
29. Martinon F, Tschopp J (2007): Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 14: 10-22. (Pubitemid 44911890)
30. Bergsbaken T, Fink SL, Cookson BT (2009): Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 7: 99-109.
31. Dostert C, Pétrilli V, Van Bruggen R, et al. (2008): Innate immune activation trough Nalp3 inflammasome sensing of asbestos and silica. Science 320: 674-677.
32. Eisenbarth SC, Colegio OR, O'Connor W, et al. (2008): Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453: 1122-1126. (Pubitemid 351871731)
33. Salnikov V, Lukyánenko YO, Frederick CA, et al. (2007): Probing the outer mitochondrial membrane in cardiac mitochondria with nanoparticles. Biophys J 92: 1058-1071.
34. Zoratti M, Szabò I (1995): The mitochondrial permeability transition. Biochim Biophys Acta 1241: 139-176.
35. Crompton M (1999): The mitochondrial permeability transition pore and its role in cell death. Biochem J 341: 233-249.
36. Siskind LJ, Kolesnick RN, Colombini M (2006): Ceramide forms channels in mitochondrial outer membranes at physiologically relevant conditions. Mitochondrion 6: 118-125. (Pubitemid 43872021)
37. Zamzami N, Kroemer G (2001): The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2: 67-71. (Pubitemid 33676964)
38. Halestrap A (2005): Biochemistry: a pore way to die. Nature 434: 578-579.